Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of multi-electrode electrostatic precipitation during intraperitoneal aerosolized drug delivery: Insights from a large animal model.

Bioengineering & translational medicine·2026
Same author

Networking is Essential for the Proper Management of Rare Cancers: From Recognition to Implementation.

Annals of surgical oncology·2026
Same author

Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data.

ImmunoTargets and therapy·2026
Same author

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be safely combined with nephrectomy in patients with appendiceal malignancy and synchronous renal cell carcinoma.

Journal of surgical case reports·2026
Same author

Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritonei.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Response to Letter Comments on Raised Serum Tumor Markers Predict Incomplete Cytoreduction, Disease-Free and Overall Survival in Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and HIPEC.

Annals of surgical oncology·2026

Related Experiment Video

Updated: Aug 4, 2025

Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens
09:19

Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens

Published on: December 9, 2022

1.8K

Determining a minimum data set for reporting clinical and radiologic data for pseudomyxoma peritonei.

Thale D J H Patrick-Brown1, Faheez Mohamed2, Andrew Thrower3

  • 1Department of Tumour Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.

Pleura and Peritoneum
|April 6, 2023
PubMed
Summary

Standardizing data collection for pseudomyxoma peritonei (PMP) research is crucial for rare cancer collaboration. This study reviews current PMP trial data, highlighting the need for more comprehensive, standardized reporting to advance treatment discovery.

Keywords:
biobankingdata scienceinvestigative techniquesneoplasmperitoneumpseudomyxoma peritonei

More Related Videos

A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions
10:21

A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions

Published on: March 3, 2023

1.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

312

Related Experiment Videos

Last Updated: Aug 4, 2025

Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens
09:19

Culture and Imaging of Ex Vivo Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens

Published on: December 9, 2022

1.8K
A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions
10:21

A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions

Published on: March 3, 2023

1.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

312

Area of Science:

  • Oncology
  • Rare Cancers
  • Clinical Research

Background:

  • Pseudomyxoma peritonei (PMP) is a rare malignancy impacting over 11,736 European patients.
  • The rarity of PMP necessitates inter-center collaboration for research advancement.
  • Standardized data collection protocols are lacking for PMP research and biobanking.

Purpose of the Study:

  • To initiate a discussion on a minimum data set for PMP research.
  • To review current clinical trial reports for PMP data collection practices.
  • To facilitate collaborative efforts in the PMP research community.

Main Methods:

  • A systematic review of PMP clinical trial reports was conducted.
  • Databases searched included PubMed, CenterWatch, ClinicalTrials.gov, and MedRxiv.
  • Selected trials reporting PMP results were analyzed for data collection consistency.

Main Results:

  • Core data points like age, sex, survival, Peritoneal Cancer Index (PCI), and cytoreduction completeness are commonly reported.
  • Significant variability exists in other reported data points beyond the core set.
  • Current reporting practices fall short of the comprehensive standardization needed for rare disease research.

Conclusions:

  • Establishing a consensus on minimum data set for PMP research is essential.
  • Increased standardization in data collection will enhance collaborative research and accelerate PMP treatment discovery.
  • Further efforts are required to achieve comprehensive and standardized data reporting in PMP studies.